Insider · CIK 0001871152
Caren Deardorf
director
Files at CRNX (Crinetics Pharmaceuticals, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -16,300 | $85.00 | $1.4M | 5,925 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Common Stock | -5,925 | $85.00 | $504k | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -35,000 | $65.70 | $2.3M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -4,375 | $66.71 | $292k | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -17,500 | $64.68 | $1.1M | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,500 | $40.29 | $504k | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,350 | $52.67 | $545k | 0 | 41 d ago |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -9,730 | $49.13 | $478k | 0 | 41 d ago |
| Jun 11, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | AGrant or award Common Stock | +6,900 | $0.00 | $0 | 16,300 | Jun 13, 2025 |
| Jun 11, 2025 | CRNX Crinetics Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +10,350 | $0.00 | $0 | 10,350 | Jun 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.